Digital therapy program for fibromyalgia receives FDA breakthrough device designation

Digital therapy program for fibromyalgia receives FDA breakthrough device designation

Digital therapy program for fibromyalgia receives FDA breakthrough device designation

Swing Therapeutics, a digital therapeutics startup, has received an FDA breakthrough device designation for their 12 week smartphone-assisted fibromyalgia management program. This is the company’s first breakthrough designation, and precedes a deluge of clini…

Read More…



Product Review